Streetbeat News

BLPH

Bellerophon Therapeutics Inc

http://www.bellerophon.com/

CEO

Fabian Tenenbaum

Employees

Industry

Pharmaceutical Preparation Manufacturing

bellerophon therapeutics is a clinical-stage biotherapeutics company focused on developing innovative products combining novel drugs and devices in the treatment of cardiopulmonary and cardiac diseases. our mission is to develop well-studied molecules deployed through innovative delivery systems to treat diseases with significant unmet clinical need.

Open

0.04

Mkt cap

453K

Volume

High

0.04

P/E Ratio

-0.04

52-wk high

0.10

Low

0.04

Div yield

N/A

52-wk low

0.03

Several healthcare stocks experienced significant movement in Friday's after-market session. Bellerophon Therapeutics, Cingulate, Rain Oncology, Artelo Biosciences, Processa Pharma, and Eiger BioPharmaceuticals saw gains, while Eloxx Pharmaceuticals, TRACON Pharma, Universe Pharmaceuticals, Purple Biotech, RVL Pharmaceuticals, and OpGen experienced losses.

Portfolio Pulse from Benzinga Insights

October 13, 2023 | 9:31 pm

During Friday's intraday session, several healthcare stocks experienced significant movements. Bio-Path Hldgs, Processa Pharma, Harpoon Therapeutics, SELLAS Life Sciences Gr, Agape ATP, and Assure Hldgs saw their stocks rise, with Bio-Path Hldgs leading the gainers with a 60.6% increase. On the other hand, Bellerophon Therapeutics, Outset Medical, Harmony Biosciences, Comera Life Sciences, Catalyst Biosciences, and PMV Pharma saw their stocks decline, with Bellerophon Therapeutics leading the losers with a 64.9% decrease.

Portfolio Pulse from Benzinga Insights

October 13, 2023 | 5:31 pm

The article lists the stocks that gained and lost the most during Friday's mid-day trading session. Among the gainers were Sigma Additive Solutions, Bio-Path Holdings, and Shift Technologies, while the losers included Bellerophon Therapeutics, Outset Medical, and MSP Recovery. The article also mentions several companies that reported better-than-expected earnings, such as Comtech Telecommunications and JPMorgan Chase, and others that lowered their guidance or reported worse-than-expected results, such as Belden and SMART Global Holdings.

Portfolio Pulse from Lisa Levin

October 13, 2023 | 5:14 pm

US stocks traded higher with the Dow Jones gaining over 200 points. JPMorgan Chase & Co reported better-than-expected earnings for Q3, with net revenue of $40.7 billion, up 21% Y/Y. Sigma Additive Solutions, Bio-Path Holdings, and Versus Systems saw significant stock increases. Outset Medical, Bellerophon Therapeutics, and Secoo Holding saw significant stock decreases.

Portfolio Pulse from Lisa Levin

October 13, 2023 | 1:48 pm

During Friday's pre-market session, several healthcare stocks experienced significant movement. Bio-Path Hldgs, Redhill Biopharma, Akari Therapeutics, TRACON Pharma, Petros Pharma, and Sera Prognostics saw increases in their stock prices. Conversely, Outset Medical, Nuwellis, Bellerophon Therapeutics, Cassava Sciences, OpGen, and Reshape Lifesciences experienced decreases.

Portfolio Pulse from Benzinga Insights

October 13, 2023 | 1:06 pm

Several healthcare stocks experienced significant movement in Thursday's after-market session. Bio-Path Hldgs, Comera Life Sciences, Scinai Immunotherapeutics, 60 Degrees, Bellerophon Therapeutics, and Relay Therapeutics saw increases, while Cassava Sciences, Outset Medical, T2 Biosystems, OpGen, Tempest Therapeutics, and BeyondSpring saw decreases.

Portfolio Pulse from Benzinga Insights

October 12, 2023 | 9:32 pm

On Tuesday, 132 companies hit new 52-week lows. Among them, Corning (NYSE:GLW) was the largest in terms of market cap, while Wheeler Real Estate IT (NASDAQ:WHLR) was the smallest. Fortress Biotech (NASDAQ:FBIO) saw the largest move with shares plummeting 1350.03%, while Insulet (NASDAQ:PODD) made the biggest bounce back, moving up 0.0% shortly after hitting a new 52-week low.

Portfolio Pulse from Benzinga Insights

October 10, 2023 | 5:09 pm

During Friday's session, 59 companies set new 52-week lows. The largest firm by market cap to set a new low was Bristol-Myers Squibb (NYSE:BMY), while the smallest was BitNile Metaverse (NASDAQ:BNMV). Tonix Pharmaceuticals (NASDAQ:TNXP) saw the largest move with shares plummeting 38.2%. ClearPoint Neuro (NASDAQ:CLPT)'s stock bounced back the most, rising 0.0% after reaching its new low.

Portfolio Pulse from Benzinga Insights

July 28, 2023 | 4:36 pm

Several healthcare stocks experienced significant movement in Friday's pre-market session. Gainers included Reata Pharmaceuticals, Bluejay Diagnostics, SIGA Technologies, Homology Medicines, Creative Medical Tech, and Asensus Surgical. Losers included Tonix Pharmaceuticals, Bellerophon Therapeutics, Femasys, Telesis Bio, Mallinckrodt, and Titan Pharma.

Portfolio Pulse from Benzinga Insights

July 28, 2023 | 1:06 pm

Several stocks are experiencing significant pre-market movements. Coursera shares are up by 15.3% following better-than-expected Q2 sales results and an upgrade from Cantor Fitzgerald. Other gainers include Unique Fabricating, Greenbrook TMS, SIGA Technologies, Homology Medicines, Inpixon, AEye, Navidea Biopharmaceuticals, Intel Corporation, and Asensus Surgical. Losers include Tonix Pharmaceuticals, Sleep Number Corporation, Bellerophon Therapeutics, Mallinckrodt, Fresh Vine Wine, Enphase Energy, Femasys, Sigma Additive Solutions, Sweetgreen, and Yoshiharu Global.

Portfolio Pulse from Lisa Levin

July 28, 2023 | 11:57 am

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.